Scientists test mRNA bird flu shots in first human trial
NCT ID NCT07019883
Summary
This early-stage study is testing two new mRNA vaccines designed to protect against H5 avian influenza (bird flu) in healthy adults. Researchers will give 80 participants different doses to check for safety and see if the vaccines trigger an immune response. The study will help determine the best dose and whether these mRNA vaccines could be developed for future bird flu outbreaks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AVIAN INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030-3411, United States
-
Duke Vaccine and Trials Unit
Durham, North Carolina, 27703, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-0011, United States
Conditions
Explore the condition pages connected to this study.